Clinical Trial Update: A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a fixed-dose combination of fluticasone furoate and levocabastine versus levocabastine and fluticasone furoate alone in allergic rhinit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• Fluticasone furoate/levocabastine fixed-dose combination (fluticasone furoate; levocabastine)
• Levocabastine (levocabastine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial and Seasonal | Phase 2 | Status: COMPLETED | Results posted: 2014-10-08